Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Regenerative and Combination Treatment Approaches for Frontal Fibrosing Alopecia
Description
The speaker describes frontal fibrosing alopecia as an inflammatory scarring hair loss disorder in which treatment should begin early, before fibrosis becomes irreversible. They emphasize that standard therapies lack strong standardized guidelines and that single treatments usually improve but rarely fully resolve disease. The main focus is on regenerative and combination approaches aimed at suppressing inflammation, supporting follicular stem cells, and improving symptoms. Technologies highlighted include low-energy light photomodulation, especially 308-nanometer light, and a 1585-nanometer non-ablative laser, which the speaker considers particularly useful for reducing inflammation, redness, and discomfort while promoting remodeling and Wnt signaling. Their practice commonly combines these with PRP and low-dose oral minoxidil, which they believe may also have anti-inflammatory effects. Exosomes are presented as a promising future therapy, and hair transplantation may be considered only after sustained disease quiescence, with continued anti-inflammatory treatment afterward. Overall, the speaker argues that early intervention, combination therapy, and more evidence-based standardized regimens are essential for better outcomes in FFA.
View moreConclusions
- The presentation concludes that frontal fibrosing alopecia is primarily an inflammatory disease that should be treated before fibrosis becomes irreversible.
- Early intervention during the pre-fibrotic window is emphasized as the most important factor for preserving hair and improving outcomes.
- Standard therapies are considered helpful but insufficient because responses are often partial, relapse is common, and there are no widely accepted treatment guidelines.
- Combination therapy is presented as the best overall strategy, integrating medications, lasers, and regenerative approaches rather than relying on any single modality.
- Non-ablative energy-based devices, especially photobiomodulation and certain fractional or Nd:YAG lasers, may reduce inflammation, improve symptoms, and support follicular signaling.
- The 1585 nm non-ablative fractional laser and 308 nm photomodulation are highlighted as especially promising technologies in the speaker’s practice.
- PRP is viewed as a useful adjunct that can decrease inflammatory activity and symptoms, but it does not reliably reverse established scarring.
- Exosomes are described as a promising future therapy, but they remain experimental and require stronger evidence and safety validation.
- Hair transplantation can offer cosmetic improvement only in carefully selected, long-stable cases, but long-term graft survival remains limited if disease activity continues.
- The field needs standardized protocols and more rigorous evidence to determine the most effective combinations and sequences of therapy for FFA.
- Aguh, Crystal, JAAD 2021.
- Ozcan D, et al. Dermatol Ther. 2019.
- Navarini AA, et al. Arch Dermatol. 2011.
- Gerkowicz A, et al. Photodiagnosis Photodyn Ther. 2019.
- Subash J, et al. Int J Womens Dermatol. 2021.
- Haddad F, et al. Journal of Cosmetic Dermatology, 2025.
- Vano-Galvan S, et al. J Am Acad Dermatol. 2019.